Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong
· Delayed Price · Currency is HKD 3.070
+0.040 (1.32%)
Mar 10, 2026, 4:08 PM HKT
HKG:1349 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 1,056 | 1,196 | 1,289 | 1,209 | Upgrade
|
| Short-Term Investments | - | - | - | 30 | - | Upgrade
|
| Cash & Short-Term Investments | 1,119 | 1,056 | 1,196 | 1,319 | 1,209 | Upgrade
|
| Cash Growth | 5.90% | -11.67% | -9.35% | 9.13% | -13.46% | Upgrade
|
| Accounts Receivable | - | 469.96 | 620.49 | 679.12 | 672.49 | Upgrade
|
| Other Receivables | - | 0.07 | 0.16 | 5.14 | 1.18 | Upgrade
|
| Receivables | - | 470.03 | 620.64 | 684.26 | 673.66 | Upgrade
|
| Inventory | - | 47.27 | 43.65 | 40.53 | 35.63 | Upgrade
|
| Other Current Assets | - | 33.2 | 9.24 | 25.1 | 9.77 | Upgrade
|
| Total Current Assets | - | 1,607 | 1,869 | 2,069 | 1,928 | Upgrade
|
| Property, Plant & Equipment | - | 503.53 | 475.33 | 351.51 | 301.92 | Upgrade
|
| Long-Term Investments | - | 257.49 | 287.53 | 306.37 | 327.86 | Upgrade
|
| Other Intangible Assets | - | 68.65 | 86.35 | 62.32 | 88.46 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 133.28 | 100.87 | 85.9 | 79.22 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 43.09 | 36.12 | Upgrade
|
| Other Long-Term Assets | - | 16.77 | 57.18 | 57.62 | 19.64 | Upgrade
|
| Total Assets | - | 2,587 | 2,877 | 2,976 | 2,781 | Upgrade
|
| Accounts Payable | - | 10.67 | 8.05 | 7.43 | 8.17 | Upgrade
|
| Accrued Expenses | - | 28.69 | 36.86 | 34.67 | 53.78 | Upgrade
|
| Short-Term Debt | - | - | - | 101 | - | Upgrade
|
| Current Portion of Leases | - | 6.1 | 6.33 | 8.22 | 8.68 | Upgrade
|
| Current Income Taxes Payable | - | - | 1.61 | 1.63 | 10.4 | Upgrade
|
| Current Unearned Revenue | - | 8.34 | 0.26 | 0.31 | 348.87 | Upgrade
|
| Other Current Liabilities | - | 197.16 | 451.9 | 520.09 | 98.3 | Upgrade
|
| Total Current Liabilities | - | 250.95 | 505.02 | 673.34 | 528.2 | Upgrade
|
| Long-Term Leases | - | 14.43 | 10.95 | 15.6 | 22.59 | Upgrade
|
| Long-Term Unearned Revenue | - | 15.85 | 2.15 | 34.04 | 40.8 | Upgrade
|
| Total Liabilities | - | 281.23 | 518.12 | 722.99 | 591.58 | Upgrade
|
| Common Stock | - | 103.66 | 103.66 | 102.9 | 104.3 | Upgrade
|
| Additional Paid-In Capital | - | 1,290 | 1,289 | 1,225 | 1,265 | Upgrade
|
| Retained Earnings | - | 916.9 | 970.46 | 934.39 | 868.43 | Upgrade
|
| Treasury Stock | - | - | - | - | -40.82 | Upgrade
|
| Comprehensive Income & Other | - | -5.55 | -5.86 | -5.2 | -4.05 | Upgrade
|
| Total Common Equity | 2,258 | 2,305 | 2,358 | 2,257 | 2,193 | Upgrade
|
| Minority Interest | - | 0.71 | 1.01 | -4.08 | -3.36 | Upgrade
|
| Shareholders' Equity | 2,259 | 2,305 | 2,359 | 2,253 | 2,190 | Upgrade
|
| Total Liabilities & Equity | - | 2,587 | 2,877 | 2,976 | 2,781 | Upgrade
|
| Total Debt | 15.95 | 20.53 | 17.28 | 124.81 | 31.26 | Upgrade
|
| Net Cash (Debt) | 1,103 | 1,036 | 1,179 | 1,194 | 1,178 | Upgrade
|
| Net Cash Growth | 6.46% | -12.12% | -1.33% | 1.43% | -14.49% | Upgrade
|
| Net Cash Per Share | 1.05 | 1.00 | 1.14 | 1.16 | 1.13 | Upgrade
|
| Filing Date Shares Outstanding | 1,808 | 1,037 | 1,037 | 1,029 | 1,032 | Upgrade
|
| Total Common Shares Outstanding | 1,037 | 1,037 | 1,037 | 1,029 | 1,032 | Upgrade
|
| Working Capital | - | 1,356 | 1,364 | 1,396 | 1,400 | Upgrade
|
| Book Value Per Share | 2.18 | 2.22 | 2.27 | 2.19 | 2.12 | Upgrade
|
| Tangible Book Value | 2,194 | 2,236 | 2,271 | 2,195 | 2,104 | Upgrade
|
| Tangible Book Value Per Share | 2.12 | 2.16 | 2.19 | 2.13 | 2.04 | Upgrade
|
| Buildings | - | 368.53 | 199.22 | 198.52 | 198.52 | Upgrade
|
| Machinery | - | 504.91 | 388.63 | 341.74 | 322.86 | Upgrade
|
| Construction In Progress | - | 7.2 | 229.96 | 122.37 | 48.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.